ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 1 of 1 for:    NCT00712426
Previous Study | Return to List | Next Study

Creatine Safety, Tolerability, & Efficacy in Huntington's Disease (CREST-E) (CREST-E)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00712426
Recruitment Status : Terminated (Results of an interim analysis showed that it was unlikely that creatine was effective in slowing loss of function in early symptomatic Huntington's Disease.)
First Posted : July 10, 2008
Last Update Posted : March 11, 2016
Sponsor:
Collaborators:
University of Rochester
National Center for Complementary and Integrative Health (NCCIH)
Information provided by (Responsible Party):
Steven M. Hersch, Massachusetts General Hospital

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Terminated
  Actual Primary Completion Date : December 2014
  Actual Study Completion Date : January 2015
  Certification/Extension First Submitted : February 10, 2016
Publications:

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):